Biogenesis
PrivateLast Round
Seed
Mar 1, 2024
Total Funding Raised
$2.75M
Company Overview
Biogenesis is a healthcare technology company that provides an AI-powered platform designed to accelerate clinical trials by matching pharmaceutical organizations with suitable clinical research sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Workflow Automation, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biogenesis Comparables
Compare Biogenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inato | 79% | |
| Paradigm Health | 75% | |
| TriNetX | 74% |
Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2024 | ||||
| Pre Seed | Oct 2, 2022 |
Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UC LAUNCH | Pre Seed |
| Alt Capital | Seed |
| Kleiner Perkins | Pre Seed |
| Nucleate | Pre Seed |
| Pareto Holdings | Pre Seed |
| Z Fellows | Pre Seed |
| Formic Ventures | Pre Seed |
Biogenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biogenesis's valuation, stock price, and market status.
Is Biogenesis a public or private company?
Biogenesis is a private company.
What is the current stock price of Biogenesis?
Biogenesis is a private company with no public stock price. No recent secondary market data is available.
How much is Biogenesis worth (valuation)?
Valuation information for Biogenesis is not publicly available.
Can I buy Biogenesis stock?
Biogenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biogenesis's last funding round?
Biogenesis's most recent funding round was Seed on March 1, 2024.
Who are the main investors in Biogenesis?
Key investors in Biogenesis include UC LAUNCH, Alt Capital, Kleiner Perkins, Nucleate, Pareto Holdings.
Will Biogenesis IPO soon?
No public IPO plans have been announced for Biogenesis.
How can I track Biogenesis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biogenesis's secondary market activity and sign up for updates.